Kansas Business Today
SEE OTHER BRANDS

Your business and economy news reporter from Kansas

Kansas Business Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kansas Business Today.

Press releases published on May 7, 2025

InnovAge Earns Recertification as a Great Place to Work

InnovAge Earns Recertification as a Great Place to Work

DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- InnovAge, a leading provider of Program of All-Inclusive Care for the Elderly (PACE) services, is proud to announce its recertification as a Great Place to Work®. This recognition reflects the company’s continued …

Akero Therapeutics to Present at the BofA Securities 2025 Healthcare Conference

Akero Therapeutics to Present at the BofA Securities 2025 Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …

HeartCore to Present at Sidoti Micro-Cap Virtual Conference on May 21, 2025 at 11:30 a.m. ET

HeartCore to Present at Sidoti Micro-Cap Virtual Conference on May 21, 2025 at 11:30 a.m. ET

NEW YORK and TOKYO, May 07, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company based in Tokyo, will be virtually presenting and holding one- …

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

1Q 2025 Total Revenue of $114.8 Million (Adjusted Total Revenue(1) of $118.6 Million), a 40% YoY Increase 1Q 2025 GAAP Net Income of $26.9 Million, a 51% YoY Increase 1Q 2025 Adjusted EBITDA(2) of $47.9 Million, an 81% YoY Increase 1Q 2025 Adjusted Net …

LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025 Cash, cash equivalents and marketable securities of $194.1 million as of March 31, 2025 Upwardly revised anticipated cash balance at …

Open Lending Reports First Quarter 2025 Financial Results

Open Lending Reports First Quarter 2025 Financial Results

AUSTIN, Texas, May 07, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (Nasdaq: LPRO) (the “Company” or “Open Lending”), an industry trailblazer in lending enablement and risk analytics solutions for financial institutions, today reported financial …

BBSI Reports Strong First Quarter 2025 Financial Results

BBSI Reports Strong First Quarter 2025 Financial Results

- Revenues up 10% to $292.6 Million with Gross Billings up 9% to $2.09 Billion - VANCOUVER, Wash., May 07, 2025 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (“BBSI” or the “Company”) (NASDAQ: BBSI), a leading provider of business management …

Noodles & Company Announces First Quarter 2025 Financial Results

Noodles & Company Announces First Quarter 2025 Financial Results

BROOMFIELD, Colo., May 07, 2025 (GLOBE NEWSWIRE) -- Noodles …

Hudson Technologies Reports First Quarter 2025 Results

Hudson Technologies Reports First Quarter 2025 Results

First quarter revenue reflects continued low refrigerant market price landscape Reports $81 million in cash and no debt at March 31, 2025 Continues share repurchase program WOODCLIFF LAKE, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. ( …

Aardvark Therapeutics to Present at Upcoming Investor Conferences in May

Aardvark Therapeutics to Present at Upcoming Investor Conferences in May

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment …

Global Crossing Airlines Reports First Quarter 2025 Financial Results

Global Crossing Airlines Reports First Quarter 2025 Financial Results

GAAP Net Income of $0.2 Million or $0.00 per Share; EBITDAR1 of $20.6 Million Revenue of $66.6 Million with Total Block Hours of 7,546 MIAMI, May 07, 2025 (GLOBE NEWSWIRE) -- Global Crossing Airlines Group, Inc. (Cboe CA: JET, Cboe CA: JET.B, OTCQB: JETMF) …

H&R Block Reports Fiscal 2025 Third Quarter Results

H&R Block Reports Fiscal 2025 Third Quarter Results

— Delivered Revenue Growth of 4%, Net Income Growth of 5%, and EPS Growth of 9% — — Improved Volume and Market Share Trends in Assisted Channel Through April 30 — — Reaffirms Full Year 2025 Outlook — KANSAS CITY, Mo., May 07, 2025 (GLOBE NEWSWIRE) -- H…

RxSight, Inc. Reports First Quarter 2025 Financial Results

RxSight, Inc. Reports First Quarter 2025 Financial Results

ALISO VIEJO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for …

Cerence Announces Second Quarter Fiscal 2025 Results; Revenue and Profitability Exceed High End of Guidance

Cerence Announces Second Quarter Fiscal 2025 Results; Revenue and Profitability Exceed High End of Guidance

Headlines Revenue of $78M; free cash flow of $13.1M marks fourth consecutive positive quarter Company reiterates full-year guidance for revenue and raises full-year guidance for profitability and cash flow Continued innovation and customer momentum for …

Encore Capital Group Announces First Quarter 2025 Financial Results

Encore Capital Group Announces First Quarter 2025 Financial Results

Favorable purchasing conditions continue in U.S. market Global portfolio purchases up 24% to $368 million, including record $316 million in U.S. Global collections up 18% to $605 million, including record $454 million in U.S. Earnings per share of $1.93 …

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

ROCKVILLE, Md., May 07, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation …

Veeco Reports First Quarter 2025 Financial Results

Veeco Reports First Quarter 2025 Financial Results

First Quarter 2025 Highlights: Revenue of $167.3 million, compared with $174.5 million in the same period last year GAAP net income of $11.9 million, or $0.20 per diluted share, compared with $21.9 million, or $0.37 per diluted share in the same period …

Euro Sun Mining Advancing Rovina Valley Project Following Strategic EU Designation

Euro Sun Mining Advancing Rovina Valley Project Following Strategic EU Designation

Euro Sun Mining Advancing Rovina Valley Project Following Strategic EU Designation TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- Euro Sun Mining Inc. (TSX: ESM) ("Euro Sun" or the "Company") is pleased to report continued progress on its Rovina Valley Project …

OraSure Announces First Quarter 2025 Financial Results

OraSure Announces First Quarter 2025 Financial Results

BETHLEHEM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended March 31, 2025 …

A-Mark Precious Metals Reports Fiscal Third Quarter 2025 Results

A-Mark Precious Metals Reports Fiscal Third Quarter 2025 Results

Q3 FY 2025 Net Loss of $8.5 Million and Q3 YTD FY 2025 Net Income of $7.0 Million Non-GAAP Adjusted Net Income of $5.7 Million and Non-GAAP EBITDA of $1.3 Million in Q3 FY 2025 Q3 FY 2025 Diluted Loss per Share of ($.36) and Q3 YTD FY 2025 Diluted Earnings …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service